OCT for Early Detection and Staging of Endobronchial Lung and Pleural Cancer, Airway Injury, and Prostate Cancer - Tabular View

Tracking Information

First Received Date ^ICMJE

December 19, 2007

Last Updated Date

March 13, 2009

Start Date ^ICMJE

March 2007

Estimated Primary Completion Date

July 2012 (final data collection date for primary outcome measure)

Current Primary Outcome Measures ^ICMJE

the OCT results are at least as accurate as the standard Pathology results. [ Time Frame: 30 minutes ] [ Designated as safety issue: No ]

Original Primary Outcome Measures ^ICMJE

Same as current

Change History

Complete list of historical versions of study NCT00581503 on ClinicalTrials.gov Archive Site

Current Secondary Outcome Measures ^ICMJE

Original Secondary Outcome Measures ^ICMJE

Descriptive Information

Brief Title ^ICMJE

OCT for Early Detection and Staging of Endobronchial Lung and Pleural Cancer, Airway Injury, and Prostate Cancer

Official Title ^ICMJE

Optical Coherence Tomography for Early Detection and Staging of Endobronchial Lung and Pleural Cancer, Airway Injury, and Prostate Cancer

Brief Summary

Optic methods for obtaining images in airway passages for early detection of endobronchial lung and pleural cancer are needed. Optical coherence tomography (OCT) is a non-invasive diagnostic technique that can provide information about tissue abnormalities. This technique uses a near-infrared diode to emit light that can produce images of the specimen under investigation without causing damage or alterations.

Detailed Description

Optical coherence tomography (OCT) is a non-invasive diagnostic technique that can provide information about tissue abnormalities. This technique uses a near-infrared diode to emit light that can produce images of the specimen under investigation without causing damage or alterations.

The research' want to compare the OCT results with that obtained from conventional histologic examination and to show that the OCT results may be almost as accurate as the standard Pathology results.

Optical coherence tomography (OCT) is a new technique being developed that can be used for visualizing human tissue. OCT offers a means of providing information on the characteristics and extent of a lesion (and abnormal change in structure of an organ).

Study Phase

Study Type ^ICMJE

Observational

Study Design ^ICMJE

Case-Only, Prospective

Condition ^ICMJE

Lung Cancer
Pleural Cancer
Prostate Cancer

Intervention ^ICMJE

Study Arms / Comparison Groups

Publications *

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information

Recruitment Status ^ICMJE

Enrolling by invitation

Estimated Enrollment ^ICMJE

Estimated Completion Date

July 2012

Estimated Primary Completion Date

July 2012 (final data collection date for primary outcome measure)

Eligibility Criteria ^ICMJE

Inclusion Criteria:

Adult 18 years and older
Having procedure of endobronchial, transbronchial, and / or pleural biopsy

Exclusion Criteria:

Currently participating in any other investigational drug or device evaluation.
Currently taking drugs that are sensitive to light.

Gender

Both

Ages

18 Years and older

Accepts Healthy Volunteers

Contacts ^ICMJE

Contact information is only displayed when the study is recruiting subjects

Location Countries ^ICMJE

United States

Administrative Information

NCT ID ^ICMJE

NCT00581503

Responsible Party

Matthew Brenner, M.D., Beckman Laser Institute,University of California, Irvine

Study ID Numbers ^ICMJE

NIH OCT-EB-02493-07, LAMMP MET RR-01192-29

Study Sponsor ^ICMJE

University of California, Irvine

Collaborators ^ICMJE

Beckman Laser Institute University of California Irvine
Chao Family Comprehensive Cancer Center
Pulmonary and Critical Care Medicine,University of California, Irvine

Investigators ^ICMJE

Principal Investigator:

Matthew Brenner, M.D

Beckman Laser Institute

Information Provided By

University of California, Irvine

Verification Date

March 2009

^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP